Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Xtant Medical Holdings (XTNT) over the last 17 years, with Q3 2025 value amounting to $11.5 million.

  • Xtant Medical Holdings' Accumulated Expenses rose 3003.04% to $11.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.5 million, marking a year-over-year increase of 3003.04%. This contributed to the annual value of $7.8 million for FY2024, which is 2541.51% down from last year.
  • Latest data reveals that Xtant Medical Holdings reported Accumulated Expenses of $11.5 million as of Q3 2025, which was up 3003.04% from $10.6 million recorded in Q2 2025.
  • In the past 5 years, Xtant Medical Holdings' Accumulated Expenses registered a high of $11.5 million during Q3 2025, and its lowest value of $4.1 million during Q3 2021.
  • Over the past 5 years, Xtant Medical Holdings' median Accumulated Expenses value was $6.3 million (recorded in 2023), while the average stood at $7.2 million.
  • As far as peak fluctuations go, Xtant Medical Holdings' Accumulated Expenses plummeted by 3250.04% in 2021, and later surged by 8957.42% in 2023.
  • Quarter analysis of 5 years shows Xtant Medical Holdings' Accumulated Expenses stood at $4.3 million in 2021, then rose by 26.37% to $5.5 million in 2022, then soared by 89.57% to $10.4 million in 2023, then fell by 25.42% to $7.8 million in 2024, then soared by 48.44% to $11.5 million in 2025.
  • Its last three reported values are $11.5 million in Q3 2025, $10.6 million for Q2 2025, and $10.5 million during Q1 2025.